Deliver Your News to the World

CybeRelease: (OTC: MTPM) Rated Speculative Buy with $3.58 Price Target


(CybeRelease, August 30, 2007) - Lake Harmony, Pa. - Mitopharm Corporation Inc. (OTC PK: MTPM) has been rated “Speculative Buy” with a target price of $3.58 by Beacon Equity Research Analyst, Lisa Springer, CFA.

The full report is available at

Anyone interested in receiving alerts regarding Mitopharm Corp. research should email with “MTPM” in the subject line.

In the report, the analyst writes, “Mitopharm Corporation (MTPM) is a development-stage biotechnology company involved in the research and development, marketing and sales of functional beverages, dietary supplements and drugs. The Company employs the latest technologies in biochemistry, pharmacology and Traditional Chinese Medicinal (TCM) formulas to research and develop new drugs. The Company’s products, Restorade and Stamina Solution, are based on a newly discovered compound, which has biochemical properties that aid in countering the effects of aging.”

To read the complete release, go to

CybeRelease Gainers are First Solar, Inc. (Nasdaq: FSLR), Sears Holdings Corporation (Nasdaq: SHLD), Foster Wheeler Ltd. (Nasdaq: FWLT), Blue Coat Systems Inc (Nasdaq: BCSI), JA Solar Holdings, Co., Ltd. (Nasdaq: JASO), MICROS Systems, Inc. (Nasdaq: MCRS) and Intuitive Surgical, Inc. (Nasdaq: ISRG).

CybeRelease Decliners are PDL BioPharma, Inc. (Nasdaq: PDLI), SourceForge, Inc. (Nasdaq: LNUX), Joy Global Inc. (Nasdaq: JOYG), Winn-Dixie Stores, Inc. (Nasdaq: WINN), Energy Conversion Devices, Inc. (Nasdaq: ENER), Triad Guaranty Inc. (Nasdaq: TGIC) and SiRF Technology Holdings, Inc. (Nasdaq: SIRF).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.